Related Experiment Video
Updated: Apr 3, 2026

Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
Role of altered mitochondria functions in the pathogenesis of systemic lupus erythematosus
B D Leishangthem1, A Sharma2, A Bhatnagar3
1Department of Biochemistry, Basic Medical Sciences Block, Panjab University, Chandigarh, India.
Abstract:
Mitochondria, main producers of reactive-oxygen species (ROS), were studied to examine their role in the pathogenesis of systemic lupus erythematosus (SLE). PBMCs and mitochondria were isolated from SLE patients and healthy volunteers for various parameters. Mitochondrial ROS, swelling, hyperpolarization and levels of cytochrome c, caspase3 in the cells were assessed by flow cytometry. ROS was significantly increased in SLE patients (SLE vs controls: 1.83 ± 1.03 vs 1.10 ± 0.35; p < 0.0001). Depolarized state of mitochondria was greater in patients (SLE vs controls: 7.10 ± 5.50% vs 2.5 ± 1.8%; p < 0.05). Mitochondria swelling was found to be significantly altered in patients (SLE vs controls: 112.65 ± 36.56 vs 60.49 ± 20.69; p < 0.001). Expression of cytochrome c and caspase 3 (SLE vs controls: 1.37 ± 0.37% vs 1.01 ± 0.03%; 1.57 ± 0.46% vs 1.06 ± 0.07%; p < 0.05) respectively was found to be significantly increased in SLE. Further, the enzymatic activity of mitochondrial complex was assessed in isolated mitochondria. A significant decrease in activity of Complex I (SLE vs controls: 11.79 ± 3.18 vs 15.10 ± 6.38 nmol NADH oxidized/min/mg protein, p < 0.05); Complex IV (SLE vs control: 9.41 ± 5.16 vs 13.56 ± 5.92 nmol cytochrome c oxidized/min/mg protein, p < 0.05) and Complex V (SLE vs controls: 4.85 ± 1.39 vs 6.17 ± 2.02 nmol ATP hydrolyzed/min/mg protein, p < 0.05) was found in SLE patients in comparison to healthy controls. However, Complex II did not show significant variation in either group (SLE vs controls: 42.2 ± 28.6 vs 61.71 ± 42.3 nmol succinate oxidized/min/mg protein; ns). The decrease in enzyme activities of mitochondrial Complexes I, IV and V on one hand and ROS, hyperpolarization and apoptosis on the other points toward a possible role of mitochondria in the pathogenesis of lupus.
Insights
Mitochondrial dysfunction, including increased reactive oxygen species (ROS) and altered enzyme activity, is implicated in systemic lupus erythematosus (SLE) pathogenesis. These findings suggest mitochondria play a key role in SLE development.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Mitochondria are central to cellular energy production and reactive oxygen species (ROS) generation.
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with complex pathogenesis.
- Mitochondrial dysfunction is increasingly recognized as a potential contributor to autoimmune diseases.
Purpose of the Study:
- To investigate the role of mitochondria in the pathogenesis of systemic lupus erythematosus (SLE).
- To assess mitochondrial function, including ROS production, membrane potential, swelling, and enzyme activity, in SLE patients compared to healthy controls.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) and isolated mitochondria were obtained from SLE patients and healthy volunteers.
- Flow cytometry was used to measure mitochondrial ROS, membrane potential, swelling, and levels of cytochrome c and caspase-3.
- Enzymatic activity of mitochondrial respiratory chain complexes (I-V) was assessed in isolated mitochondria.
Main Results:
- SLE patients exhibited significantly increased mitochondrial ROS production, mitochondrial swelling, and elevated levels of cytochrome c and caspase-3 compared to controls.
- Mitochondria in SLE patients showed a greater depolarized state.
- Activities of mitochondrial Complex I, Complex IV, and Complex V were significantly decreased in SLE patients, while Complex II activity remained unchanged.
Conclusions:
- The observed increase in ROS, mitochondrial depolarization, swelling, and apoptosis markers, coupled with decreased activity of key mitochondrial complexes, strongly suggests a significant role for mitochondrial dysfunction in SLE pathogenesis.
- Targeting mitochondrial pathways may offer novel therapeutic strategies for SLE.
Related Concept Videos
Mitochondria
ATP Synthase: Mechanism
Mitochondrial Membranes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

